The FDA recently granted approval of Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. Because of you, research continues to advance and there is now another treatment option that can give people living with Alzheimer’s more time. 

Slowing down the disease is critical, but we cannot stop here. New and better treatments for Alzheimer's are urgently needed.  Continuing to invest in research is the only way we can hope to find a cure for Alzheimer's. It is research that creates breakthroughs and makes advancements toward a cure possible.

My inspiration for Walking is my brother and his wife who were caretakers for her mom who was diagnosed a few years ago.  They provided exceptional care for her and were honored that they were able to do this for her.

Please donate to advance the care, support and research efforts of the Alzheimer's Association.